logo.gif
PGS Refinancing Completed
December 19, 2005 03:13 ET | PGS ASA
December 19, 2005: OSLO, NORWAY - Petroleum Geo-Services ASA ("PGS" or the "Company") (OSE and NYSE: PGS) announced today that it has entered into a new $1 billion senior secured credit facility (the...
logo.gif
PGS Refinancing Completed
December 19, 2005 03:13 ET | PGS ASA
December 19, 2005: OSLO, NORWAY - Petroleum Geo-Services ASA ("PGS" or the "Company") (OSE and NYSE: PGS) announced today that it has entered into a new $1 billion senior secured credit facility (the...
AFRY_Logotyp_Liggande_Explainer_FINALE.png
Jaakko Pöyry Group expands its operations in Italy
December 19, 2005 03:03 ET | AFRY
Electrowatt-Ekono, which is part of the Jaakko Pöyry Group's Energy business group, has expanded its operations in Europe by acquiring 70 per cent of the shares of the Italian company S.P.E Servizi...
AFRY_Logotyp_Liggande_Explainer_FINALE.png
Jaakko Pöyry Group laajentaa toimintaansa Italiassa
December 19, 2005 03:03 ET | AFRY
Electrowatt-Ekono, joka kuuluu Jaakko Pöyry Groupin Energia-liiketoimintaryhmään, on laajentanut toimintaansa Euroopassa ostamalla 70 prosenttia Genovassa toimivan S.P.E Servizi per l'Energia -yhtiön...
UTi Worldwide Announces Management Promotions; Realigns EMENA Region Management Structure Around Client Solutions and Solutions Delivery
December 19, 2005 03:01 ET | UTi Worldwide
RANCHO DOMINGUEZ, Calif., Dec. 19, 2005 (PRIMEZONE) -- UTi Worldwide Inc. (Nasdaq:UTIW) today announced the promotions of Carlos Escario to president of client solutions and Ruediger Klug to...
Converium Holding AG: Report on Restatement and Third Quarter Results 2005
December 19, 2005 02:39 ET | Converium Holding AG
-- Following the restatement of accounts, shareholders' equity as of June 30, 2005 increases by US$ 69.3 million to US$ 1,717.5 million. -- For the third quarter of 2005, Converium...
Active Biotech Advan
Active Biotech Advances 57-57 Project
December 19, 2005 02:30 ET | Active Biotech
  In addition, a number of biological markers will be monitored to determine the effect of 57-57 on disease progression.   This multi-centre dose-escalation study is being conducted at...
Active Biotech har s
Active Biotech har startat klinisk prövning med patienter för projektet 57-57
December 19, 2005 02:30 ET | Active Biotech
Vidare kommer ett antal biologiska markörer att studeras för att ge en uppfattning om 57-57s eventuella påverkan på sjukdomsförloppet.   Denna multicenter, dos-eskaleringsstudie genomförs på...
Epigenomics DNA Methylation Test Successfully Detects Colorectal Cancer in Blood
December 19, 2005 02:15 ET | Epigenomics AG
BERLIN, Germany and SEATTLE, Dec. 19, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced...
NOVARTIS logo.jpg
Novartis erwägt Vorteile einer Akquisition von Berna Biotech
December 19, 2005 02:00 ET | Novartis Pharma AG
Novartis erhält Gelegenheit zur Durchführung einer Due Diligence bei Berna Die zentralen wirtschaftlichen Bedingungen eines möglichen Angebots sind noch nicht bestimmt, es besteht keine...